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Abstract
HIV-1 entry into host cells is mediated by interactions between the V3-loop of viral glycopro-
tein gp120 and chemokine receptor CCR5 or CXCR4, collectively known as HIV-1 corecep-
tors. Accurate genotypic prediction of coreceptor usage is of significant clinical interest and
determination of the factors driving tropism has been the focus of extensive study. We have
developed a method based on nonlinear support vector machines to elucidate the interact-
ing residue pairs driving coreceptor usage and provide highly accurate coreceptor usage
predictions. Our models utilize centroid-centroid interaction energies from computationally
derived structures of the V3-loop:coreceptor complexes as primary features, while addi-
tional features based on established rules regarding V3-loop sequences are also investi-
gated. We tested our method on 2455 V3-loop sequences of various lengths and subtypes,
and produce a median area under the receiver operator curve of 0.977 based on 500 runs
of 10-fold cross validation. Our study is the first to elucidate a small set of specific interacting
residue pairs between the V3-loop and coreceptors capable of predicting coreceptor usage
with high accuracy across major HIV-1 subtypes. The developed method has been imple-
mented as a web tool named CRUSH, CoReceptor USage prediction for HIV-1, which is
available at http://ares.tamu.edu/CRUSH/.
Introduction
In recent years, significant advances in the treatment of human immunodeficiency virus type 1
(HIV-1) have been made, and one class of drugs that has contributed to that success is inhibi-
tors that target chemokine receptors CCR5 and CXCR4, collectively known as the HIV-1 core-
ceptors [1]. For some HIV-1 viral strains these therapeutics, including maraviroc, are able to
circumvent the difficulties of thwarting the quickly mutating HIV-1 by targeting host cell core-
ceptors and inhibiting a key interaction with the third variable region of HIV-1 gp120
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(V3-loop) necessary for entry into host cells. The situation is further complicated by HIV-1
tropism, or the ability of the virus to change the cell type infected, with the transition from a
CCR5-specific (R5) virus to a CXCR4-specific (X4) virus often indicating a progression to
advanced stages of infection for subtype B viruses [2]. Therefore, tropism determination is per-
formed in conjunction with coreceptor inhibitors to ensure the success of a treatment regimen.
Phenotypic methods, such as the Trofile assay, can be costly with a slow turn-around. As an
alternative, genotypic methods based on sequencing the V3-loop and using bioinformatics
methods to predict coreceptor usage can also be used [3,4].
Ever since the HIV-1 coreceptors were identified [5–8], there has been significant interest in
understanding what drives HIV-1 coreceptor usage. Multiple rules have been established to
predict the transition from an R5- to an X4-virus. Increase in the positive net charge of the
V3-loop has been shown to favor CXCR4 (referred as Rule I) [9–11], as does a positively
charged residue at V3-loop positions 11, 24, or 25 (so-called 11/24/25 rule, referred here as
Rule II) [12]. Additionally, the loss of a highly conserved glycosylation motif (referred here as
Rule III) found at V3-loop positions 6–9 is also associated with an X4-virus [13]. A simple sta-
tistical model has been proposed that combines the three established rules to provide probabili-
ties for HIV-1 coreceptor usage given binary/discrete values for the rules [9]. More elaborate
bioinformatics methods have also been previously developed that provide improved accuracy
and sensitivity [14–18]. For more details regarding bioinformatics analysis of HIV-1, the
authors refer to the review by Aiamkitsumrit et al. [19].
With the availability of x-ray crystallographic structures of the V3-loop [20,21], a new gen-
eration of structure-based methods have been developed [22–24]. Sander et al. [22] introduced
structural descriptors that described the spatial arrangement of functional groups within
V3-loop sequences based on binned distance distributions. A more elaborate method based on
a discretized description of the electrostatic hull surrounding the V3-loop was developed by
Dybowski et al. [23]. Most recently, Bozek et al. [24] utilized an approach similar to that used
by Sander et al., but instead utilized the values of 54 amino acid indices mapped to spheres rep-
resenting each V3-loop sequence. However, none of these methods, nor to the best of our
knowledge any other existing methods, utilize structural details of the specific interactions
between the V3-loop and chemokine receptors CCR5/CXCR4 to predict HIV-1 coreceptor
usage.
Recently, structural data regarding the interactions between the HIV-1 proteins and their
ligands [25–28], including computationally derived structures of CCR5/CXCR4:V3-loop com-
plexes developed by our group [29,30], have provided molecular level details of HIV-1. How-
ever, to date, the specific interactions driving tropism have yet to be identified. Even in the
context of the recent insights into the structure of V3-loop:coreceptor complexes [29,30], pre-
diction of HIV coreceptor usage remains a highly complex problem. Capturing the effects of
V3-loop mutations on coreceptor usage first requires a selection of key V3-loop:coreceptor
interactions out of the thousands possible, since interactions driving coreceptor usage may be
energetically small and long-range. Efficient modeling of the energetics of the interactions is
also important, in order to allow the analysis of the thousands of known V3-loop sequences.
Furthermore, GPCRs are highly structurally flexible, which implies that different V3-loop
sequences could have different binding modes. To this end, we have developed a multifaceted
hybrid approach for investigating the interactions that drive coreceptor usage, using tools from
computational biophysics, structural bioinformatics, and machine learning, as illustrated by
Fig 1. Our proposed method is of similar spirit to other recent computational methods that
combine potential energy calculations with machine learning to investigate protein interactions
[31,32]. Molecular dynamics (MD) simulations were used to investigate structural and physi-
cochemical variability of V3-loop:coreceptor complexes. Biophysical insights were converted
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into structural bioinformatics features using a statistical centroid-centroid force field [33].
Nonlinear support vector machines (SVM) were trained to predict coreceptor usage based on
the four rules (Net charge, 11/24/25, motif, length), and extracted V3-loop:coreceptor interac-
tions. Finally, a novel non-linear feature selection algorithm was used to narrow down the nec-
essary and sufficient V3-loop:coreceptor interacting pairs.
Methods
Dataset
A combination of V3-loop sequences from the Los Alamos HIV database (downloaded on
April 17, 2014) and datasets published in three previous studies was used (Dybowski et al. [23],
Bozek et al. [24], and Sander et al. [22]) was collected, which contained 824 CXCR4 tropic and
8389 CCR5 tropic sequences in total. The data was filtered by first identifying unique sequences
only, and by removing sequences with special characters. V3-loop sequences that did not begin
Fig 1. Flowchart of hybrid modeling approach.
doi:10.1371/journal.pone.0148974.g001
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and end in cysteine were also removed. Finally, sequences with contradicting coreceptor usage
in different sets/patients were also removed. This resulted in a superset of non-redundant
V3-loop sequences containing 235 CXCR4 tropic and 2220 CCR5 tropic sequences that were
used for all training and testing of SVMmodels, which is provided in S1 Dataset. Since phylo-
genetic relationships between sequences derived from the same patient may bias observed
accuracies, we have also identified a subset of our superset, which contains one sequence per
patient and is referred to as the unique patient subset. The unique patient subset contains 114
CXCR4 tropic and 967 CCR5 tropic sequences, and is provided in S2 Dataset.
Molecular dynamics and interaction energies
The starting points for our molecular modeling were the computationally-derived structures of
CCR5/CXCR4:V3-loop complexes that were previously developed by our group using a frame-
work that combines rigid protein docking and molecular dynamics simulations [29,30,34].
CD-HIT Suite [35] was used to select clusters of representative HIV-1 gp120 V3 loop
sequences based on the Los Alamos dataset. Eight CCR5 recognizing and nine CXCR4 recog-
nizing HIV-1 gp120 V3 loop sequences were selected. We initially modeled the structures of
the representative HIV-1 gp120 V3 loop peptide sequences in complex with the corresponding
receptors, CCR5 and CXCR4, based on the docked-and-minimized conformations which were
used to produce the lowest binding free energy complex in [29,30]. The mutations were per-
formed using CHARMM [36], and the initial conformation-orientation of the mutated side
chains was preserved with regard to the initial conformation-orientation of the sidechains of
[29,30].
All MD simulations and free energy calculations were performed using CHARMM. For
each HIV-1 gp120 V3 loop:receptor complex, we performed two sets of MD simulations. The
setup of the system and the parametrization used in both MD simulations sets were the same
as that used in [29,30]. In the first set of MD simulations, we used the same equilibration and
production run protocol that was used in [29,30]. In this study, the production run was equal
to 4 ns. Upon the completion of the production run of each MD simulation, we performed a
binding free energy analysis of the produced complex structures, and selected the lowest bind-
ing free energy complex structure per trajectory, which was provided as an input structure to
the second set of MD simulations. In the second set of MD simulations, the selected structures
from the first MD simulations were initially subjected to a slight equilibration prior to the pro-
duction run. During the equilibration run, each complex structure was simulated for 200 ps
during which the backbone-side chain atoms were constrained to their initial positions by a
force constant equal to 1.0–0.4 kcal/molÅ2. Subsequently, the entire complex was simulated
for 100 ps with no constraints, so as to further relax the conformation of each complex struc-
ture prior to the final collection of structures in the production runs. During the production
run, the complex structures were simulated for 5 ns, and snapshots were collected every 200 ps.
For each HIV-1 gp120 V3 loop:receptor complex, the average residue pair wise interaction free
energy for all interacting pairs was calculated using all twenty-five production run snapshots.
The methodology used to calculate the residue pairwise interaction free energies was per-
formed in a heterogeneous dielectric environment and is analytically described in references
[29,30].
Filtering of interacting pairs and interaction extraction
Simulations of CCR5 tropic sequences were considered separately from simulations of CXCR4
tropic sequences. Interacting pairs with median interaction energy of< -1 kcal/mol across the
either 8 trajectories of CCR5 tropic sequences or 9 trajectories of CXCR4 tropic sequences
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were selected. Also, only interacting pairs involving amino acids of the V3-loop positions for
which no amino acid is observed in more than 90% of the representative sequences were con-
sidered. Distances for each selected interacting residue pair were extracted from the lowest
binding free energy snapshots of the first set of MD simulations for each of the representative
sequences. Therefore, for each interacting pair from CCR5 we collected 8 distances and for
each interacting residue pair from CXCR4 we collected 9 distances. The distances were con-
verted to the distance bins that are present in the centroid to centroid distance bin force field
that has be previously been described by our group [33].
Based on the selected interacting pairs and the extracted distance bin values, distance bin
interaction energies were computed for each residue pair while using every sequence in our
V3-loop superset. This was achieved by changing the V3-loop residues of the interacting pairs
according to each sequence and recording the corresponding energy values for every observed
distance bin. The minimum energy based on all possible distance bins is assigned for each
interacting pair in each sequence. This resulted in an interaction table composed of 104 col-
umns (one for each interacting pair) and 2455 rows (one for each V3-loop sequence). Addi-
tionally, the values for three established rules for coreceptor usage prediction (net charge, 11/
24/25 rule, glycosylation motif) [9,12,13] were also computed for every sequence. We also pro-
pose a fourth rule, based on the length of the V3-loop, or the number of residues including the
first and last cysteine, which is denoted as Rule IV and was also computed for every sequence.
Interaction selection
In this work, the SVMmodel refers to the l2-norm formulation with kernel K(xi, xj). A well-
known method for feature reduction utilizing SVMs with a linear kernel is the recursive feature
elimination (RFE)-SVM algorithm[37], where at each iteration, the feature k with the lowest
magnitude element w2k of the weight vector w is eliminated from the feature basis. Usage of
nonlinear kernels requires solving the dual formulation of the SVMmodel; in general, the
weight vector cannot be calculated explicitly. The Hadamard product can be used to associate
each instance vector xi with a selection vector z:
xi xi  z::
We propose the following criterion, based on the objective function of the dual formulation,
which characterizes feature k’s importance in a given feature basis:
critk ¼ 
1
2
X
i
X
j
ai a

j yiyj
@Kðxi  z;xj  zÞ
@zk

z¼1
;
where ai ; a

j are the optimal values of the dual variables, yi, yj are the class labels (parameters
taking on the values of -1, 1), and z = 1 indicates zk = 1, 8k. Thus, the iterative algorithm for
feature reduction is as follows:
For each iteration; remove feature k ¼ arg maxkfcritkg:
Note that this is equivalent to the RFE-SVM algorithm when performing linear classifica-
tion, i.e., when K(xi, xj) = xi  xj. The algorithm has been implemented in Python/C using the
libsvm library [38].
This nonlinear SVM feature selection was applied to the problem of interaction selection by
starting with 104 interactions serving as the SVM feature basis, and iteratively removing one
interaction at a time down to a single interaction. Since the interaction selection requires a
training set as input, interaction selection was performed 100 times using 100 randomly
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selected training sets, which resulted in 100 sets of N interactions for N from 104 to 1. Consen-
sus sets were created for a given number of interactions N, by taking the N interactions that
were selected most often at that stage of the algorithm. Additional runs of interaction selection
were performed while also including one or more established rules as features, but these addi-
tional features were never eliminated.
SVM training and validation
Following interaction selection, the R [39] package e1071 [40] was used to train SVMmodels
based on the Gaussian radial basis function using libsvm library for every identified feature set.
In addition to a class prediction, the SVMmodels were trained to predict an associated proba-
bility for each prediction. Given a set of features 500 runs of 10-fold cross validation were per-
formed based on the superset of V3-loop sequences. Based on the number of available CXCR4
tropic sequences, each test set contained 24 of each class, while the training sets contained 211
of each class. Since there are almost 10 times as many CCR5 tropic sequences as CXCR4 tropic
sequences, for a given a selected set of CXCR4 tropic training samples, 10 sets of CCR5 tropic
training samples were also selected and 10 SVMmodels trained. This was performed in order
to take full advantage of all available data, and therefore, for each feature set 50,000 SVMs were
trained and the average of the probabilities of the 10 SVMmodels was utilized. During the
cross-validation runs, the accuracy of feature sets was evaluated generating receiver operator
curves calculated within R and the area under the curve (AUC) was calculated using the
pracma R package [41]. Additional metrics of accuracy were also computed including the clas-
sification accuracy, calculated as the percent of the samples for which the coreceptor usage was
predicted correctly, and the sensitivity at a false positive rate (FPR) of 0.05%.
Comparison with other methods
In order to compare CRUSH to existing methods, we split our 2455 V3-loop sequences into a
training set, consisting of the 1294 sequences that were found in Dybowski et al. [23], referred
as the Dybowski set, and a test set consisting of the remaining 1161 sequences. To avoid bias, a
second model based on the 15 features of the all rules model was trained using the Dybowski
set. However, the Dybowski set only contains about 7 times as many CCR5 tropic sequences as
CXCR4 tropic sequences, therefore 7 SVMmodels were trained rather than the 10 SVMmod-
els used for cross validation. We contacted the developers of geno2pheno to compare our data-
sets in order to perform an unbiased comparison, but they declined to provide the data.
Instead we have trained a model based on a binary representation of aligned V3-loop
sequences, referred as g2p, as described by Bozek et al. [24]. g2p has been used previously by
the authors of geno2pheno as an alternative for comparing to geno2pheno[coreceptor] due to
differences in training sets. Our implementation of g2p involved first aligning all 2455 V3-loop
sequences, plus the V3-loop sequence from PDB structure 2B4C [20], using MAFFT [42]. The
resulting multiple sequence alignment had a width of 57, which resulted in 1140 total binary
features that were used to train an SVMmodel as described for CRUSH above. The reduced
CRUSH model, T-CUP2 [43], the probit method of Kieslich et al. [9], and g2p [24] were
applied to the 1161 sequence test set. The T-CUP2 R package was used in testing, while R code
was written to compute probit probabilities according to Table 5 of Kieslich et al. [9]. Addition-
ally, a similar benchmark was also performed using the unique patient subset by training a
CRUSH model on the 708 sequences (625 CCR5/ 83 X4) of the unique patient subset that were
found in the Dybowski set and testing the methods on the remaining 373 sequences (342
CCR5/ 31 CXCR4).
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To test accuracy across the major HIV-1 subtypes, additional subtype specific test sets were
extracted from the 1161 sequence test set described above. The 1161 sequences contained both
CCR5-specific and CXCR4-specific sequences for four major subtypes, A/AG, AE, B, and C (as
defined in [18]), resulting in four subtype specific test sets. The sequences of these four major
subtypes compose over 75 percent of the 1161 sequences, while the remaining sequences
belong to minor subtypes or have been assigned to multiple subtypes. For comparison, the
reduced CRUSHmodel and PhenoSeq [18] subtype specific models were applied to each of the
subtype specific test sets. Subtype specific test sets were also derived from the unique patient
subset for further validation.
Results
We initially modeled the structures of representative HIV-1 gp120 V3-loop peptide sequences
(8 CCR5 tropic and 9 CXCR4 tropic) in complex with the corresponding receptors based on
complex structures from [29,30]. Molecular dynamics simulations and free energy calculations
were performed so as to improve the conformational properties of each HIV-1 gp120 V3-loop
sequence in complex with each receptor, and to investigate which are the critical interactions
formed between different HIV-1 gp120 V3-loop sequences in complex with the two receptors.
To identify interacting residue pairs important for V3-loop binding to CCR5 and CXCR4, sim-
ulations of CCR5 tropic sequences were considered separately from simulations of CXCR4
tropic sequences. To reduce the number of residue pairs, only interacting pairs with median
interaction energy of< -1 kcal/mol across the either 8 trajectories of CCR5 tropic sequences or
9 trajectories of CXCR4 tropic sequences were considered in subsequent modeling. According
to our molecular dynamics simulations and filtering criteria we identified 52 interacting resi-
due pairs for CCR5 and 52 interacting residue pairs for CXCR4 (Tables A and B in S1 Tables).
We collected residue pair distances from our molecular dynamics simulations, and computed
the minimum centroid-centroid energies for every interacting pair based on every V3-loop
sequence of our superset.
A novel nonlinear feature selection algorithm was applied to the problem of interacting resi-
due pair selection by starting with 104 interactions serving as the SVM feature basis, and itera-
tively removing one interaction at a time down to a single interaction. To investigate the
contribution of the rules (Net charge, 11/24/25, motif, length) to coreceptor usage prediction,
interaction selection was performed six times while also including one or more rules as features
that were not considered for removal (Fig 2A). Given a set of interactions and/or rules, 500
runs of 10-fold cross validation were performed based on a superset of V3-loop sequences,
resulting in over 30 million SVMs being trained in total for this study.
During the cross-validation runs, the accuracy of feature sets was evaluated by calculating
the area under the receiver operator curve (AUC), where a value of 1 represents a perfect classi-
fication. Additionally, the sensitivity at a false positive rate of 0.05 was also calculated. Of the
624 sets of interactions/rules that were evaluated for predictive utility, the best model in terms
of accuracy with the fewest features is summarized in Table 1. Our model utilizes only 15 total
features (11 interactions and 4 rules), while other existing methods have hundreds of features
[24], which is significant when considering that balanced training sets contain only ~400
samples.
The identified interacting residue pairs alone provide highly accurate predictions (Fig 2A,
dashed line), with a maximum interactions only accuracy of 0.969 being achieved for a set of
18 interactions (Fig 3B). This result is evidence for the validity of the selected interacting resi-
due pairs and the computational models from which they were derived [29,30]. As is illustrated
by Fig 2A, it is clear that fewer interactions are needed to obtain a high level of accuracy when
Intermolecular Interactions Driving HIV-1 Tropism
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using the rules as additional features, since the rules only model (Fig 2A, zero interactions) pro-
vides an AUC of 0.910. Of the four evaluated rules, net charge was the only rule to perform as
well as all rules, but only once additional interactions were added. Electrostatically driven pro-
tein association has been proposed to be composed of two steps: recognition, which results in
an initial encounter complex and is driven by long range electrostatic interactions; binding,
which involves short and medium range interactions (both polar and nonpolar), and results in
a specific bound complex [44]. Therefore, the absence of rules that capture aspects of the bind-
ing step can be over come by introducing additional interactions, while rules inferring details
of recognition may not be fully captured by adding additional interactions. Net charge captures
the global electrostatic characteristics of the V3-loop that drive the recognition stage of associa-
tion, and as a result additional interactions are not able to account for absence of net charge as
a feature. The contributions of each of the rules is further illustrated by Fig 2B based on the
accuracy of all possible combinations of the rules with the same 11 interactions (Fig 3A). Net
charge (Q) outperformed all combinations in which net charge was not used, including four
combinations of multiple rules.
For the interactions only model, interactions with two additional V3-loop position not
found in all rules case was added, positions 12 and 24. The interactions with position 24 most
likely help accommodate for the absence of the 11/24/25 rule. The interaction with position 12
Fig 2. Effect of the rules and V3-loop:coreceptor interactions included in SVMmodels on prediction accuracy. (A) The effect of the number of
V3-loop:coreceptor interactions on accuracy. Accuracy is represented by the median AUC for 500 runs of 10-fold cross validation for both panels A and B.
The accuracy at zero interactions is the accuracy based on only the rules. (B) Contribution of rules to accuracy when used in addition to the top 11
interactions Fig 3A. The naming scheme is as follows: Int Only–interactions only; Q–net charge; R – 11/24/25 rule; M–glycosylation motif; L–length. Dashed
red line illustrates the accuracy when using all four rules and the top 11 interactions (QLMR, 0.977).
doi:10.1371/journal.pone.0148974.g002
Table 1. Summary of best coreceptor usagemodel.
Number of interacting residue pairs 11
Additional rules Net charge, 11/24/25 rule, Motif, Length
Median AUCa 0.977
Median sensitivity at 0.05 FPRa 0.917
a Results based on 500 runs of 10-fold cross-validation.
doi:10.1371/journal.pone.0148974.t001
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involves Lys 191 of CCR5, which also participates in an interaction with V3-loop position 11.
Interestingly, position 12 is often hydrophobic in CCR5 and CXCR4 tropic sequences, while
position 11 tends to be occupied by a polar amino acid (Fig 3). One interaction selected for the
all rules case was not selected for the interactions only model, V3-loop residue 18 with CCR5
Tyr 251.
Of the interactions identified by this study (Fig 3), thirteen have been previously associated
with HIV-1 coreceptor activity by experiments summarized in [29,30], and four additional res-
idue pairs are only one position away from an experimentally identified interaction. However,
three of the CXCR4 interactions identified in this study (V3 13 –CXCR4 Phe 29; V3 13 –
CXCR4 Ala 180; V3 24 –CXCR4 Pro 27) have not been previously suggested to contribute to
V3-loop binding. The participating residues were in proximity in the previously predicted
structures, but did not meet the energy threshold to grant mentioning [29,30]. These three
interactions were most likely identified in this study since we considered multiple representa-
tive R5- and X4-tropic sequences in complex with CCR5 or CXCR4.
In this study, V3-loop position 11 is found to be most important for determining coreceptor
selection, with four selected interactions in the all rules+interactions model (Fig 3A) and an
additional two interactions selected in the interactions only model (Fig 3B). Positions 5, 13 and
18 all are involved in two interactions selected in the all rules model, while position 13 is
Fig 3. Diagrams of the top selected interactions for the cases of all rules + interactions and interactions only. (A) Interaction map for the 11
interactions selected in combination with all rules. V3-loop is shown as an idealized loop with 35 amino acids where grey circles indicate positions for which
no interactions were selected (inactive), while green circles indicate V3-loop positions with interactions selected (active). Red triangles represent residues of
CCR5 and blue squares represent residues of CXCR4, with dashed lines representing interactions with V3-loop residues. Ordered lists of observed amino
acids (based on occurrence with a minimum of 5%) in one-letter code for each active V3-loop residue are provided. Observed amino acids for CCR5 tropic
sequences are in red and those observed for CXCR4 tropic sequences in blue. Bolded letters in the ordered list of observed amino acids indicate an amino
acid that is observed in at least 50% of sequences at a given position. (B) Interaction map for the 18 interactions selected without rules. Color scheme and
layout is the same as in (A). Faded triangles/squares indicate interactions that were also selected when including all rules. The crossed out interaction was
selected when including rules, but not when using interactions only.
doi:10.1371/journal.pone.0148974.g003
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involved in an additional two interactions in the interactions only model. V3-loop position 24
is also involved in two interactions, but only in the interactions only model. Sander et al. [22]
also identified V3-loop residues 11,13, 22, and 24 (denoted as 306, 308, 317, and 319) as being
important for coreceptor usage. Dybowski et al. [23] also points to V3-loop position 11 as
being key to tropism, while of the residues identified by Bozek et al. [24] only postions 12 and
24, which were identified by the interactions only model, overlap with the residues identified
by this study.
Based on the all rules model we have developed a web tool named CoReceptor USage pre-
diction for HIV-1 (CRUSH). The implementation is very efficient, since CRUSH does not
require expensive calculations, such as molecular dynamics simulations, not even a sequence
alignment, and all features are computed by either simple character counting, for the case of
the four rules, or by a table lookup, for the eleven interactions (see S1 Text for more details). In
order to compare CRUSH to existing methods we trained an additional model based on the 15
features of the all rules model using only the 1294 V3-loop sequences from the superset that
were also used by Dybowski et al. [23] (see Methods). The remaining 1161 sequences in our
superset were used as a test set to compare three recent methods T-CUP2 [43], probit [9], and
g2p [24], which were selected since the source code is available or could be implemented
locally, allowing for testing on such a large test set. Tables 2 and 3 summarize the method
comparison.
On the test set, CRUSH provides at least a 10% improvement in sensitivity, at a FPR of 0.02
or 0.05, when compared to all three methods (Table 2). The accuracy of CRUSH is reduced
when using the unique patient subset (Table 3), but the accuracies observed for the competing
methods are also reduced, resulting in the ranking of methods being the same when consider-
ing either one or multiple sequences per patient. Previously reported accuracies for T-CUP2
[43] and g2p [24] are comparable to those obtained on our test set. The accuracy of the
CRUSH web tool is expected to be even higher, since the model used for method comparison
was trained on about half as many V3-loop sequences. All methods were tested on the same
computer using R [39] implementations, and the total computational times required by each
method to make predictions for the entire test set are included in Table 2. CRUSH is almost
Table 2. Comparison of methods on test set (1161 sequences).
Method Sensitivity at FPR 0.02 Sensitivity at FPR 0.05 Number of features Total test CPU time (sec)
CRUSH 0.797 0.892 15 0.59
Probit 0.723 0.811 3 0.13
T-CUP2 0.635 0.770 70 222.46
g2p* 0.486 0.676 1140 -
* The g2p method as described by Bozek et al. [24] requires that a sequence alignment be performed on the entire dataset prior to training/testing
preventing an equal comparison of CPU time.
doi:10.1371/journal.pone.0148974.t002
Table 3. Method accuracy comparison on unique patient test set (373 sequences).
Method Sensitivity at FPR 0.02 Sensitivity at FPR 0.05
CRUSH 0.677 0.839
probit 0.645 0.742
T-CUP2 0.581 0.774
g2p 0.161 0.258
doi:10.1371/journal.pone.0148974.t003
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400 times faster than T-CUP2, which is actually an improved implementation of the method
developed by Dybowski et al. [23]. CRUSH is also substantially more efficient than the method
developed by Bozek et al. [24], whose web server warns that the computational time for each
sequence could be as much as 30 seconds. The speed of the probit method, however, is compa-
rable to CRUSH, which is due to the fact that the probit prediction is simply a table lookup
given the values for net charge, the glycosylation motif, and 11/24/25 rule, while CRUSH
requires a function evaluation given the values of the 15 features.
In recent years, an area of significant interest has been the use of next generation sequenc-
ing, which could produce well over 1 million reads per sample, to predict HIV-1 coreceptor
usage [45–48]. Therefore, computationally efficient methods for HIV-1 coreceptor prediction,
capable of analyzing very large datasets, are needed. The authors of T-CUP2 have recently
released, gCUP [45], an implementation of T-CUP2 optimized for GPUs, that was developed
for use with next generation sequencing data and is able to make predictions for over 175,000
sequences per second using GPUs. Given that gCUP is an optimized implementation of
T-CUP2, and CRUSH is significantly more efficient than T-CUP2, an optimized/parallel
implementation of CRUSH could definitely be applied to next generation sequencing analysis
and should be the focus of future work.
Another important consideration for genotypic prediction of HIV-1 coreceptor usage is
whether a method can provide accurate predictions across the major HIV-1 subtypes, since
many methods require an alignment to a reference sequence and have been developed for
HIV-1 subtype B. To evaluate the accuracy of CRUSH on different HIV-1 subtypes we have
decomposed our test set into four subtype specific test sets (Tables 4 and 5), and utilized the
reduced CRUSHmodel to predict coreceptor usage. For comparison, the suite of subtype spe-
cific models, PhenoSeq [18], was also applied to the subtype specific test sets and results are
summarized by Tables 4 and 5. The PhenoSeq suite does not provide a prediction score, only a
classification; therefore, the AUC values reported for PhenoSeq are calculated using three-
point ROC curves based on the specificity and sensitivity of the classification. Additionally, the
Table 4. Comparison of HIV-1 subtype accuracies for test set.
Subtype (# X4/# R5) CRUSH AUC CRUSH Sensitivity* PhenoSeq AUC PhenoSeq Sensitivity PhenoSeq Speciﬁcity
A/AG (4/65) 0.758 0.750 0.721 0.750 0.692
AE (6/53) 0.994 1.000 0.981 1.000 0.962
B (29/490) 0.957 0.931 0.861 0.966 0.757
C (13/227) 0.987 1.000 0.899 1.000 0.797
Total (52/876) 0.953 0.942 0.869 0.962 0.777
* CRUSH sensitivity is based on a probability threshold that produces the corresponding PhenoSeq speciﬁcity.
doi:10.1371/journal.pone.0148974.t004
Table 5. Comparison of HIV-1 subtype accuracies for unique patient test set.
Subtype (# X4/# R5) CRUSH AUC CRUSH Sensitivity* PhenoSeq AUC PhenoSeq Sensitivity PhenoSeq Speciﬁcity
A/AG (4/33) 0.758 0.750 0.784 0.750 0.818
AE (1/25) 1.000 1.000 0.980 1.000 0.960
B (4/95) 0.889 0.750 0.754 0.750 0.758
C (9/59) 1.000 1.000 0.915 1.000 0.831
Total (18/233) 0.922 0.889 0.852 0.889 0.815
* CRUSH sensitivity is based on a probability threshold that produces the corresponding PhenoSeq speciﬁcity.
doi:10.1371/journal.pone.0148974.t005
Intermolecular Interactions Driving HIV-1 Tropism
PLOSONE | DOI:10.1371/journal.pone.0148974 February 9, 2016 11 / 15
reported sensitivity for CRUSH in Tables 4 and 5 is the sensitivity achieved by CRUSH given
the corresponding specificity of PhenoSeq for each test set.
Table 4 shows that CRUSH provides AUC accuracy of greater than 0.95 overall, as well as
for three of the four subtype specific test sets, while producing higher AUC accuracies than
PhenoSeq for all four subtype sets. For subtype B (Table 4), as well as for the total set, PhenoSeq
produces a higher sensitivity than CRUSH, but at very poor specificity values of 0.757 and
0.777, respectively. To put this into context, a specificity of 0.757 or 0.777 implies that over
20% of CCR5 sequences are misclassified as CXCR4, and therefore hypothetically would be
falsely excluded from CCR5 antagonist treatment. Since PhenoSeq only provides a classifica-
tion and not a score, PhenoSeq cannot be tuned to provide a specificity that falls into the range
0.95 to 0.98 that is typically used when evaluating HIV-1 coreceptor prediction.
Based on the unique patient subset (Table 5), the sensitivity of CRUSH equals that of Pheno-
Seq for every subtype, as well as for the test set as a whole. However, Table 5 shows that CRUSH
provides a 7% improvement in the total AUC accuracy for the unique patient subset, and also
produces a higher AUC accuracy for every subtype except A/AG. The subtype specific accuracies
observed for the test sets containing multiple sequences per patient (Table 4) and one sequence
per patient (Table 5) are similar, and both illustrate the accuracy of CRUSH across subtypes.
CRUSH provides comparable accuracy across major subtypes because it does not utilize sequence
alignments to template sequences and therefore is not limited to specific subtypes.
At present time, the CRUSH server has yet to be validated in a clinical setting, which is to be
the focus of future studies. In the current implementation, the CRUSH server provides a probabil-
ity score for each submitted V3-loop sequence, but clinically relevant thresholds have yet to be
established. For the test set results summarized in Table 2, a probability threshold of ~0.90 pro-
vided a specificity of 0.98 while a probability of ~0.75 provided a specificity of 0.95. These probabil-
ity cutoffs could be used as a rule of thumb until clinically relevant thresholds can be established.
In summary, we have identified a finite set of eleven interactions that can be used to accu-
rately predict coreceptor usage. The manner in which the mutations affect the interactions
with the coreceptors is highly nonlinear, since sequences specific to CCR5 or CXCR4 could
contain the same amino acids at some positions. Our proposed nonlinear SVMmodels, made
available through the CRUSH server, are able to decipher these complex relationships, provid-
ing highly accurate predictions of coreceptor usage with potential utility for clinical settings.
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